Annual ROE
-31.68%
+75.36%+70.40%
December 31, 2024
Summary
- As of March 10, 2025, FOLD annual return on equity is -31.68%, with the most recent change of +75.36% (+70.40%) on December 31, 2024.
- During the last 3 years, FOLD annual ROE has risen by +52.69% (+62.45%).
- FOLD annual ROE is now -124.69% below its all-time high of 128.30%, reached on December 31, 2003.
Performance
FOLD ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-35.23%
+35.94%+50.50%
December 31, 2024
Summary
- As of March 10, 2025, FOLD quarterly return on equity is -35.23%, with the most recent change of +35.94% (+50.50%) on December 31, 2024.
- Over the past year, FOLD quarterly ROE has stayed the same.
- FOLD quarterly ROE is now -111.43% below its all-time high of 308.25%, reached on June 30, 2007.
Performance
FOLD Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
FOLD ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.4% | 0.0% |
| 3 y3 years | +62.5% | +75.5% |
| 5 y5 years | +63.6% | +75.5% |
FOLD ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.2% | at high | +75.5% |
| 5 y | 5-year | at high | +71.2% | at high | +75.5% |
| alltime | all time | -124.7% | +90.1% | -111.4% | +84.4% |
Amicus Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -31.68%(-70.4%) | -35.23%(-50.5%) |
| Sep 2024 | - | -71.17%(-20.4%) |
| Jun 2024 | - | -89.45%(-22.4%) |
| Mar 2024 | - | -115.21%(-4.1%) |
| Dec 2023 | -107.04%(-2.6%) | -120.19%(-16.5%) |
| Sep 2023 | - | -143.95%(-0.1%) |
| Jun 2023 | - | -144.06%(+8.7%) |
| Mar 2023 | - | -132.58%(+9.3%) |
| Dec 2022 | -109.93%(+30.3%) | -121.31%(+12.9%) |
| Sep 2022 | - | -107.43%(+0.2%) |
| Jun 2022 | - | -107.25%(+10.2%) |
| Mar 2022 | - | -97.32%(+11.5%) |
| Dec 2021 | -84.37%(+16.2%) | -87.26%(+5.9%) |
| Sep 2021 | - | -82.38%(-6.5%) |
| Jun 2021 | - | -88.07%(+12.6%) |
| Mar 2021 | - | -78.21%(+4.3%) |
| Dec 2020 | -72.59%(-16.6%) | -74.96%(+7.1%) |
| Sep 2020 | - | -70.00%(+14.1%) |
| Jun 2020 | - | -61.34%(-6.4%) |
| Mar 2020 | - | -65.56%(-11.0%) |
| Dec 2019 | -86.99%(-13.3%) | -73.65%(+0.6%) |
| Sep 2019 | - | -73.23%(-21.6%) |
| Jun 2019 | - | -93.37%(+1.9%) |
| Mar 2019 | - | -91.61%(+15.0%) |
| Dec 2018 | -100.32%(+25.9%) | -79.67%(+5.7%) |
| Sep 2018 | - | -75.35%(+8.8%) |
| Jun 2018 | - | -69.25%(-7.6%) |
| Mar 2018 | - | -74.91%(-10.3%) |
| Dec 2017 | -79.66%(+41.0%) | -83.51%(+2.9%) |
| Sep 2017 | - | -81.19%(+25.3%) |
| Jun 2017 | - | -64.79%(+1.4%) |
| Mar 2017 | - | -63.91%(+8.0%) |
| Dec 2016 | -56.51%(+0.5%) | -59.17%(+9.7%) |
| Sep 2016 | - | -53.92%(+4.6%) |
| Jun 2016 | - | -51.56%(+0.1%) |
| Mar 2016 | - | -51.50%(-0.1%) |
| Dec 2015 | -56.22% | -51.54%(-8.8%) |
| Sep 2015 | - | -56.51%(-20.1%) |
| Jun 2015 | - | -70.74%(-38.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | -114.69%(-7.3%) |
| Dec 2014 | -82.09%(-20.9%) | -123.70%(-24.5%) |
| Sep 2014 | - | -163.86%(+2.3%) |
| Jun 2014 | - | -160.12%(+8.1%) |
| Mar 2014 | - | -148.09%(+16.4%) |
| Dec 2013 | -103.74%(+5.1%) | -127.23%(+17.6%) |
| Sep 2013 | - | -108.17%(+14.2%) |
| Jun 2013 | - | -94.72%(+26.0%) |
| Mar 2013 | - | -75.17%(+1.5%) |
| Dec 2012 | -98.74%(+5.1%) | -74.03%(-7.3%) |
| Sep 2012 | - | -79.83%(+3.4%) |
| Jun 2012 | - | -77.19%(-14.5%) |
| Mar 2012 | - | -90.27%(-6.9%) |
| Dec 2011 | -93.97%(+17.0%) | -96.98%(-4.7%) |
| Sep 2011 | - | -101.72%(+0.0%) |
| Jun 2011 | - | -101.70%(+13.3%) |
| Mar 2011 | - | -89.74%(+6.4%) |
| Dec 2010 | -80.34%(+774.2%) | -84.31%(+629.3%) |
| Sep 2010 | - | -11.56%(+37.9%) |
| Jun 2010 | - | -8.38%(-32.7%) |
| Mar 2010 | - | -12.45%(+9.5%) |
| Dec 2009 | -9.19%(-79.6%) | -11.37%(-87.3%) |
| Sep 2009 | - | -89.42%(+30.2%) |
| Jun 2009 | - | -68.66%(+25.1%) |
| Mar 2009 | - | -54.89%(+24.0%) |
| Dec 2008 | -45.15%(-85.9%) | -44.25%(+11.8%) |
| Sep 2008 | - | -39.58%(+2.3%) |
| Jun 2008 | - | -38.68%(+7.9%) |
| Mar 2008 | - | -35.86%(-44.8%) |
| Dec 2007 | -319.35%(-634.1%) | -64.99%(-71.2%) |
| Sep 2007 | - | -225.92%(-173.3%) |
| Jun 2007 | - | 308.25%(+467.9%) |
| Mar 2007 | - | 54.28%(-9.2%) |
| Dec 2006 | 59.79%(+7.3%) | 59.79%(-46.1%) |
| Sep 2006 | - | 110.95%(+19.9%) |
| Jun 2006 | - | 92.54%(+24.8%) |
| Mar 2006 | - | 74.14%(+33.0%) |
| Dec 2005 | 55.74%(-56.6%) | 55.74% |
| Dec 2003 | 128.30% | - |
FAQ
- What is Amicus Therapeutics annual return on equity?
- What is the all time high annual ROE for Amicus Therapeutics?
- What is Amicus Therapeutics annual ROE year-on-year change?
- What is Amicus Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly ROE year-on-year change?
What is Amicus Therapeutics annual return on equity?
The current annual ROE of FOLD is -31.68%
What is the all time high annual ROE for Amicus Therapeutics?
Amicus Therapeutics all-time high annual return on equity is 128.30%
What is Amicus Therapeutics annual ROE year-on-year change?
Over the past year, FOLD annual return on equity has changed by +75.36% (+70.40%)
What is Amicus Therapeutics quarterly return on equity?
The current quarterly ROE of FOLD is -35.23%
What is the all time high quarterly ROE for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly return on equity is 308.25%
What is Amicus Therapeutics quarterly ROE year-on-year change?
Over the past year, FOLD quarterly return on equity has changed by 0.00% (0.00%)